Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyroxine replacement therapy

A D Toft1

  • 1Department of Medicine, Royal Infirmary, Edinburgh, Scotland.

Annals of the Academy of Medicine, Singapore
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Determining the correct thyroxine dose is debated, with questions about TSH suppression risks for osteoporosis and ischemic heart disease in subclinical hypothyroidism. Some hypothyroidism cases may resolve spontaneously.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme.

Diabetes, obesity & metabolism·2012
Same author

Effects of eccentric cycling exercise on IGF-I splice variant expression in the muscles of young and elderly people.

Scandinavian journal of medicine & science in sports·2007
Same author

Controversies in radioiodine therapy: relation to ophthalmopathy, the possible radioprotective effect of antithyroid drugs, and use in large goitres.

European journal of endocrinology·2002
Same author

Strenuous exercise decreases the percentage of type 1 T cells in the circulation.

Journal of applied physiology (Bethesda, Md. : 1985)·2001
Same author

Plasma interleukin-6 during strenuous exercise: role of epinephrine.

American journal of physiology. Cell physiology·2001
Same author

Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population.

The Journal of clinical endocrinology and metabolism·2001
Same journal

Singapore expert consensus on optimising lipid-lowering strategies in acute coronary syndrome: A modified Delphi study.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Association of estimated pulse wave velocity with 28-day mortality in sepsis: A MIMIC-IV study.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Prognostic value of the monocyte-to-albumin ratio in nasopharyngeal carcinoma: A retrospective cohort study.

Annals of the Academy of Medicine, Singapore·2026
Same journal

A multicomponent control programme in nursing homes in Singapore.

Annals of the Academy of Medicine, Singapore·2026
Same journal

2025 Singapore consensus statements on the management of osteoporosis.

Annals of the Academy of Medicine, Singapore·2026
Same journal

The effect of pulse steroid therapy on bone density and turnover: A systematic review and meta-analysis.

Annals of the Academy of Medicine, Singapore·2026
See all related articles

Area of Science:

  • Endocrinology
  • Thyroidology
  • Metabolic Bone Disease

Background:

  • Debate exists regarding optimal thyroxine replacement therapy dosage.
  • The potential risks of suppressed serum TSH (thyroid-stimulating hormone) levels, particularly concerning osteoporosis, are under discussion.
  • The association between subclinical hypothyroidism and increased risk of ischemic heart disease remains unclear.

Purpose of the Study:

  • To explore the controversies surrounding thyroxine replacement therapy.
  • To investigate whether suppressed TSH levels are a risk factor for osteoporosis.
  • To assess the risk of ischemic heart disease in patients with subclinical hypothyroidism.

Main Methods:

  • Analysis of current literature and clinical guidelines.

Related Experiment Videos

  • Review of studies examining TSH suppression and bone density.
  • Examination of epidemiological data on ischemic heart disease in hypothyroid patients.

    • Main Results:

    • No universal consensus on the correct thyroxine dose or the risks of TSH suppression.
    • Uncertainty regarding TSH suppression as a risk factor for osteoporosis.
    • Lack of agreement on whether subclinical hypothyroidism increases ischemic heart disease risk.

    Conclusions:

    • Optimal thyroxine dosage and the implications of TSH suppression require further investigation.
    • The relationship between subclinical hypothyroidism and cardiovascular risk needs clarification.
    • Recognition of potential spontaneous remission of hypothyroidism, even after long-term thyroxine treatment.